Kazakh man dies after second Russian COVID-19 vaccine dose in Almaty
Kazakh man dies after second Russian COVID-19 vaccine dose in Almaty
Kazakh man dies after second Russian COVID-19 vaccine dose in Almaty
Almaty's Public Health Department has commented on the death of 42-year-old Bakhytzhan Nurtazin following an anti-COVID vaccination, reports a correspondent for Almaty.tv.
On April 12, Nurtazin received his first dose of the Russian-made vaccine. After the injection, he remained under observation for 30 minutes and reported no adverse reactions. Twenty-one days later, he received the second component of the vaccine. The procedure followed standard protocol, after which he returned home. There, he suddenly fell ill and died before an ambulance arrived.
"Based on preliminary findings, the cause of death appears to be acute cardiovascular failure. An investigation is underway to determine the exact circumstances, and a forensic medical examination has been initiated. We have been informed that the results will be ready in June and will be disclosed once available," said Laura Myrzagali, acting deputy head of the city's Public Health Department.
Retired midwife faces her own type 2 diabetes diagnosis after pandemic lifestyle shifts
She spent years guiding others through health crises—now, she's applying that expertise to her own battle with blood sugar. The pandemic changed everything.
New Yorkers demand action as aircraft noise threatens health and peace
The roar of low-flying planes keeps families awake—and doctors warn it's more than an annoyance. A new study reveals hidden health dangers, sparking a battle for quieter skies.
EU Police Mission in Palestine Accused of Secrecy and Threatening Press Freedom
A decade-long investigation sparks a showdown over accountability. Why is the EU's police mission in Palestine hiding its ties to US officials—and silencing critics?
Minnesota's top trauma hospital fights to stay open amid funding crisis
A cancer survivor's life was saved here—but now Hennepin Healthcare may close. Lawmakers race to fund Minnesota's most vital emergency care center.